Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

891.68 +46.37 (+5.49%)
Official Closing Price Updated: 7:00 PM EDT, Aug 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,587,696
Open 860.00
Bid (Size) 892.10 (3)
Ask (Size) 892.65 (2)
Prev. Close 845.31
Today's Range 860.00 - 908.49
52wk Range 516.57 - 966.10
Shares Outstanding N/A
Dividend Yield 0.51%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Stocks to Load-Up On Before Autumn Arrives
Consider these stocks to buy before autumn as each has delivered strong financial results and seen their share price rise as a result. 
Via InvestorPlace
Lilly Stock Surging On Healthy Profits: Check Out Who's On The IBD 50, Other Premium Lists
Lilly last week reported an 86% surge in earnings to $3.92 a share, easily beating estimates, as revenue popped 35% to $11.3 billion. 
Via Investor's Business Daily

Performance

YTD
+50.57%
+50.57%
1 Month
-4.55%
-4.55%
3 Month
+17.68%
+17.68%
6 Month
+20.95%
+20.95%
1 Year
+68.79%
+68.79%

More News

Read More
S&P 500 Erases Weekly Losses, Nasdaq 100 Ends 4-Week Slide As Bulls Regain Momentum: Friday's Stock Movers At The Close
Via Benzinga
Topics Stocks
Exposures US Equities
Eli Lilly's Q2 Sales Surge 36%, Analysts Cautious On Future Supply, Market Dynamics; Optimistic About Next-Gen Oral Weight-Loss Drug
Via Benzinga
Wall Street Momentum Stalls After Thursday's Rally, Palantir Jumps To 3-Year Highs, Bonds Rally: What's Driving Markets Friday?
Via Benzinga
Expedia Posts Upbeat Earnings, Joins Akamai Technologies, Trade Desk, DXC Technology And Other Big Stocks Moving Higher On Friday
Via Benzinga
3 Healthcare Stocks to Sell in August Before They Crash & Burn
Via InvestorPlace
Analyzing Eli Lilly In Comparison To Competitors In Pharmaceuticals Industry
Via Benzinga
Stock Market Rally Begins After Global Rout; Palantir, Eli Lilly, Fortinet Jump: Weekly Review
Via Investor's Business Daily
Eli Lilly Unusual Options Activity
Via Benzinga
Why Eli Lilly Stock Just Jumped 8%
Via The Motley Fool
Novo Nordisk's Shares Go on a Rollercoaster Ride After Earnings
Via MarketBeat
Topics ETFs
Prediction: This Weight Loss Stock Will Be Acquired Within the Next Year
Via The Motley Fool
Eli Lilly & Co. Stocks Elliott Wave Technical Analysis - Friday, August 9
Via Talk Markets
It's Too Soon to Buy the Dip in Weight Loss Drugmakers
Via MarketBeat
2 Healthcare Stocks to Buy Hand Over Fist in August
Via The Motley Fool
S&P 500 Records Best Session Since January 2023: Investor Sentiment Improves, But Greed Index Remains In 'Extreme Fear' Zone
Via Benzinga
Topics Stocks
Exposures US Equities
Eli Lilly Shatters Q2 Estimates, Boosts Annual Guidance on Mounjaro and Zepbound Surge
Via Chartmill
Eli Lilly (LLY) Q2 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Dow Jumps Over 500 Points; Eli Lilly Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Parker-Hannifin Posts Upbeat Earnings, Joins Under Armour, Zillow Group, YETI Holdings, Eli Lilly And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Eli Lilly And Company Shines In Q2 With $11.30B Revenue, 68% EPS Growth
Via Talk Markets
LLY Stock Alert: Why Are Eli Lilly Shares Surging Today?
Via InvestorPlace
Mounjaro Maker Eli Lilly's Bumper Q2 Earnings Exceeds Estimates, Hikes Outlook Again On Strong Diabetes And Weight Loss Drugs Sales
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.